Physical activity, body mass index, and prostaglandin E2 levels in rectal mucosa

Journal of the National Cancer Institute

Volumn 91, Issue 11, 1999, Pages 950-953

  Martínez, María Elena ^a   Heddens, David ^b   Earnest, David L ^b   Bogert, Cheryl L ^b   Roe, Denise ^a   Einspahr, Janine ^b   Marshall, James R ^a   Alberts, David S ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E2;

ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; COLON CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RADIOIMMUNOASSAY; RECTUM MUCOSA; TISSUE LEVEL;

EID: 0345120595     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.11.950     Document Type: Article

References (43)

1. Martinez ME, Giovannucci E, Spiegelman D, Hunter DJ, Willett WC, Colditz GA. Leisure-time physical activity, body size, and colon cancer in women. Nurses' Health Study Research Group. J Natl Cancer Inst 1997;89: 948-55.
2. Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 1995;122: 327-34.
3. Slattery ML, Caan BJ, Potter JD, Berry TD, Coates A, Duncan D, et al. Dietary energy sources and colon cancer risk. Am J Epidemiol 1997;145:199-210.
4. Colditz GA, Cannuscio CC, Frazier AL. Physical activity and reduced risk of colon cancer: implications for prevention. Cancer Causes Control 1997;8:649-67.
5. Lee IM, Paffenbarger RS Jr. Change in body weight and longevity. JAMA 1992;268: 2045-9.
6. Le Marchand L, Wilkens LR, Mi MP. Obesity in youth and middle age and risk of colorectal cancer in men. Cancer Causes Control 1992;3: 349-54.
7. Kune GA, Kune S, Watson LF. Body weight and physical activity as predictors of colorectal cancer risk. Nutr Cancer 1990;13:9-17.
8. Bartram HP, Wynder EL. Physical activity and colon cancer risk? Physiological considerations. Am J Gastroenterol 1989;84:109-12.
9. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995;6:164-79.
10. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 1994;3: 687-95.
11. Karmali RA. Prostaglandins and cancer. CA Cancer J Clin 1983;33:322-32.
12. Bennett A, Del Tacca M. Proceedings: prostaglandins in human colonic carcinoma. Gut 1975;16:409.
13. Jaffe BM, Parker CW, Philpott GW. Immunochemical measurement of prostaglandin or prostaglandin-like activity from normal and neoplastic cultured tissue. Surg Forum 1971; 22:90-2.
14. Bennett A, Tacca MD, Stamford IF, Zebro T. Prostaglandins from tumours of human large bowel. Br J Cancer 1977;35:881-4.
15. Pugh S, Thomas GA. Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2. Gut 1994;35: 675-8.
16. Furuta Y, Hall ER, Sanduja S, Barkley T Jr, Milas L. Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin. Cancer Res 1988;48:3002-7.
17. Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;325:1593-6.
18. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, et al. Aspirin use and risk of colorectal cancer in women. N Engl J Med 1995;333:609-14.
19. Martínez ME, McPherson RS, Levin B, Annegers JF. Aspirin and other nonsteroidal antiinflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals. Cancer Epidemiol Biomarkers Prev 1995;4:703-7.
20. Shiff SJ, Rigas B. Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions. Gastroenterology 1997;113:1992-8.
21. Taylor HL, Jacobs DR Jr, Shucker B, Knudsen J, Leon AS, Debacker G. A questionnaire for the assessment of leisure time physical activities. J Chronic Dis 1978;31:741-55.
22. Folsom AR, Jacobs DR Jr, Caspersen CJ, Gomez-Marin O, Knudsen J. Test-retest reliability of the Minnesota Leisure-time Physical Activity Questionnaire. J Chronic Dis 1986;39: 505-11.
23. Richardson MT, Leon AS, Jacobs DR Jr, Ainsworth BE, Serfass R. Comprehensive evaluation of the Minnesota Leisure-time Physical Activity Questionnaire. J Clin Epidemiol 1994; 47:271-81.
24. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR Jr, Montoye HJ, Sallis JF, et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993;25:71-80.
25. Finley PR, Bogert CL, Alberts DS, Einspahr J, Earnest DL, Blackwell G, et al. Measurement of prostaglandin E2 in rectal mucosa in human subjects: a method study. Cancer Epidemiol Biomarkers Prev 1995;4:239-44.
26. Littell RC, Milliken GA, Stroup WW, Wolfinger RD. SAS system for mixed models. Cary (NC): SAS Institute; 1996.
27. Kayaleh RA, Meshkinpour H, Avinashi A, Tamadon A. Effect of exercise on mouth-to-mouth cecum transit in trained athletes: a case against the role of runners' abdominal bouncing. J Sports Med Phys Fitness 1996;36:271-4.
28. Robertson G, Meshkinpour H, Vandenberg K, James N, Cohen A, Wilson A. Effects of exercise on total and segmental colon transit. J Clin Gastronenterol 1993;16:300-3.
29. Coenen C, Wegener M, Wedmann B, Schmidt G, Hoffmann S. Does physical exercise influence bowel transit time in healthy young men? Am J Gastroenterol 1992;87:292-5.
30. Koivisto VA, Yki-Jarvinen H, DeFronzo RA. Physical training and insulin sensitivity. Diabetes Metab Rev 1986;1:445-81.
31. Regensteiner JG, Mayer EJ, Shetterly SM, Eckel RH, Haskell WL, Marshall JA, et al. Relationship between habitual physical activity and insulin levels among nondiabetic men and women. San Luis Valley Diabetes Study. Diabetes Care 1991;14:1066-74.
32. Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991;14:1132-43.
33. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982; 54:254-60.
34. Watkins LF, Lewis LR, Levine AE. Characterization of the synergistic effects of insulin and transferrin and the regulation of their receptors on a human colon carcinoma cell line, Int J Cancer 1990;45:372-5.
35. Koenuma M, Yamori T, Tsuruo T. Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn J Cancer Res 1989;80:51-8.
36. Bjork J, Nilsson J, Hultcrantz R, Johansson C. Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29. Scand J Gastroenterol 1993; 28:879-84.
37. Johnson DG, Fujimoto WY, Williams RH. Enhanced release of insulin by prostaglandins in isolated pancreatic islets. Diabetes 1973;22: 658-63.
38. Pek S, Tai TY, Elster A, Fajans SS. Stimulation by prostaglandin E2 of glucagon and insulin release from isolated rat pancreas. Prostaglandins 1975;10:493-502.
39. McCarthy TL, Casinghino S, Mittanck DW, Ji CH, Centrella M, Rotwein P. Promoterdependent and -independent activation of insulin-like growth factor binding protein-5 gene expression by prostaglandin E2 in primary rat osteoblasts. J Biol Chem 1996;271:6666-71.
40. Pash JM, Delany AM, Adamo ML, Roberts CT Jr, LeRoith D, Canalis E. Regulation of insulin-like growth factor 1 transcription by prostaglandin E2 in osteoblast cells. Endocrinology 1995;136:33-8.
41. Fournier T, Riches DW, Winston BW, Rose DM, Young SK, Noble PW, et al. Divergence in macrophage insulin-like growth factor-I (IGF-I) synthesis induced by TNF-alpha and prostaglandin E2. J Immunol 1995;155:2123-33.
42. Wolf AM, Hunter DJ, Colditz GA, Manson JE, Stampfer MJ, Corsano KA, et al. Reproducibility and validity of a self-administered physical activity questionnaire, Int J Epidemiol 1994;23:991-9.
43. Chasan-Taber S, Rimm EB, Stampfer MJ, Spiegelman D, Colditz GA, Giovannucci E, et al. Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals. Epidemiology 1996;7:81-6.